Seaport Therapeutics, Inc. · NASDAQ:SPTX
PAUL STEVEN M reported a 6.30% stake in Seaport Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 5, 2026
PAUL STEVEN M reported a 6.30% stake in Seaport Therapeutics, Inc., 3,516,718 shares, as a passive investor on Jun 30, 2026. Filed Aug 5, 2026 (Schedule 13G).
- Stake
- 6.30%
- Shares
- 3,516,718
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| PAUL STEVEN M | 6.30% | 3,516,718 |
Source
Related
- Seaport Therapeutics, Inc.
- Paul Steven M
- Seaport Therapeutics, Inc. shareholders
- Schedule 13G · PureTech Health plc · Aug 14, 2026
- Schedule 13G · Zohar Daphne · Aug 5, 2026
- Form 4 · Hombach Robert J. · Jun 24, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 11, 2026
- Schedule 13D · General Atlantic, L.P. · May 11, 2026